Requires a new public report on foreign investment in US drug making and DNA tech.
This bill would require the Federal Trade Commission (FTC) to create an annual report. This report would look at how much foreign money is invested in making drugs in the US and in DNA technology. The public would then get to see a summary of this report, helping everyone understand potential impacts on drug supply and innovation.
Today, no law requires the Federal Trade Commission to regularly report on foreign investment in US drug making or DNA technology. If this bill becomes law, the FTC would be required to produce an annual report. Starting about one year after it passes, this report would detail these investments and their effects on US supply chains and production capacity. A public summary of this report would also be made available online.
S 4987 · 119th Congress · July 15, 2026 · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers